Hyperthermia Blog

News and Opinions About Our Industry

The ESHO 35 (European Society of Hyperthermic Oncology) just wrapped up in Cologne, Germany last week. Representing Pyrexar at the event was the team from Dr. Sennewald Medizintechnik. Dr. Sennewald is the primary sponsor of this year's event and has supported this event since its founding.

Sennewald booth at ESHO 35 in Cologne, Germany 

The event was held at the KOMED event center in the MediaPark in downtown Cologne. The conference included two days of lectures and presentations covering all aspects of thermal therapy advancements. It is often an opportunity for researchers to present status updates on ongoing projects.  Dr. Dario Rogriques, Assistant Professor of Radiation Oncology at the University of Maryland School of Medicine presented the details of an upcoming animal study for the Pyrexar Hal.o head applicator for the treatment of glioblastoma.

ESHO 35 Dr. Rodrigues, University of MarylandDr. Rodriques's program objective is to evaluate numerically the feasibility of focused heating in the minipig brain using the noninvasive MR-compatible brain applicator (Hal.o) and assess the feasibility of partial brain heating to design blood perfusion measurement experiments to improve the accuracy of temperature simulations using large mammal data.  A full-scale prototype has been built and tested to verify heating performance.

Hal.o Hyperthermia Brain Applicator from Pyrexar